Cargando…
Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics
BACKGROUND: Little is known about how pharmaceutical companies lobby authorities or experts regarding procurement or the use of vaccines and antivirals. This paper investigates how members of Denmark’s pandemic planning committee experienced lobbying efforts by Roche, manufacturer of Tamiflu, the an...
Autores principales: | Vilhelmsson, Andreas, Mulinari, Shai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166586/ https://www.ncbi.nlm.nih.gov/pubmed/28977398 http://dx.doi.org/10.1093/pubmed/fdx101 |
Ejemplares similares
-
IF-02 Successful Control of Influenza Using Stockpile of Tamiflu® during 2003/2004 SARS Period
por: Su, Ih-Jen
Publicado: (2009) -
Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs
por: Mulinari, Shai, et al.
Publicado: (2020) -
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003–2012
por: Vilhelmsson, Andreas, et al.
Publicado: (2016) -
Optimizing Tactics for Use of the U.S. Antiviral Strategic National Stockpile for Pandemic Influenza
por: Dimitrov, Nedialko B., et al.
Publicado: (2011) -
Correction: Optimizing Tactics for Use of the U.S. Antiviral Strategic National Stockpile for Pandemic Influenza
por: Dimitrov, Nedialko B., et al.
Publicado: (2011)